Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mather

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 31, 2025
Interim estimates of vaccine effectiveness against influenza A(H1N1)pdm09 and A(H3N2) during a delayed influenza season, Canada, 2024/25Lea Separovic, Yuping Zhan, Samantha E Kaweski, et al.
Influenza and Other Respiratory Viruses|March 5, 2026
Effectiveness of 2024/25 KP.2 Vaccine Against Outpatient COVID-19 in CanadaLea Separovic, Suzana Sabaiduc, Yuping Zhan, et al.
Journal of Medicinal Chemistry|July 25, 2008
Discovery of 2-chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (EP128265, MPI-0441138) as a potent inducer of apoptosis with high in vivo activityNilantha Sirisoma, Shailaja Kasibhatla, Azra Pervin, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 16, 2024
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)Danuta M Skowronski, Yuping Zhan, Samantha E Kaweski, et al.
British Medical Journal|August 7, 1971
Acute myocardial infarction: home and hospital treatmentH G Mather, N G Pearson, K L Read, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 11, 2024
Association between delayed outbreak identification and SARS-CoV-2 infection and mortality among long-term care home residents, Ontario, Canada, March to November 2020: a cohort studyKevin A Brown, Sarah A Buchan, Adrienne K Chan, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Interim 2025/26 LP.8.1 vaccine effectiveness estimates against COVID-19 from the Canadian Sentinel Practitioner Surveillance Network (SPSN): insights into possible impact of influenza and other respiratory virus co-circulationDanuta M Skowronski, Yuping Zhan, Samantha E Kaweski, et al.
Clinical Pharmacology and Therapeutics|December 9, 1997
Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constantsA Tran, E Rey, G Pons, et al.
Epilepsia|July 10, 2002
Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patientsR C Sachdeo, S K Sachdeo, R H Levy, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 6, 2026
Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026Lea Separovic, Suzana Sabaiduc, Yuping Zhan, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 31, 2025
Interim estimates of vaccine effectiveness against influenza A(H1N1)pdm09 and A(H3N2) during a delayed influenza season, Canada, 2024/25Lea Separovic, Yuping Zhan, Samantha E Kaweski, et al.
Influenza and Other Respiratory Viruses|March 5, 2026
Effectiveness of 2024/25 KP.2 Vaccine Against Outpatient COVID-19 in CanadaLea Separovic, Suzana Sabaiduc, Yuping Zhan, et al.
Journal of Medicinal Chemistry|July 25, 2008
Discovery of 2-chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (EP128265, MPI-0441138) as a potent inducer of apoptosis with high in vivo activityNilantha Sirisoma, Shailaja Kasibhatla, Azra Pervin, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 16, 2024
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)Danuta M Skowronski, Yuping Zhan, Samantha E Kaweski, et al.
British Medical Journal|August 7, 1971
Acute myocardial infarction: home and hospital treatmentH G Mather, N G Pearson, K L Read, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 11, 2024
Association between delayed outbreak identification and SARS-CoV-2 infection and mortality among long-term care home residents, Ontario, Canada, March to November 2020: a cohort studyKevin A Brown, Sarah A Buchan, Adrienne K Chan, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Interim 2025/26 LP.8.1 vaccine effectiveness estimates against COVID-19 from the Canadian Sentinel Practitioner Surveillance Network (SPSN): insights into possible impact of influenza and other respiratory virus co-circulationDanuta M Skowronski, Yuping Zhan, Samantha E Kaweski, et al.
Clinical Pharmacology and Therapeutics|December 9, 1997
Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constantsA Tran, E Rey, G Pons, et al.
Epilepsia|July 10, 2002
Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patientsR C Sachdeo, S K Sachdeo, R H Levy, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 6, 2026
Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026Lea Separovic, Suzana Sabaiduc, Yuping Zhan, et al.
Pageof 10